Increased cytoplasmatic expression of cancer immune surveillance receptor CD1d in anaplastic thyroid carcinomas

ConclusionsAnaplastic thyroid carcinomas show significantly higher expression of CD1d, a receptor for NKT cells, which are subject of several anticancer therapy studies. These results may offer a novel approach to explore immunotherapeutic treatment options.

Source: Cancer Medicine - September 26, 2019 Category: Cancer & Oncology Authors: Florian Weber, Henrik Junger, Jens M. Werner, Natalia Velez Char, Carolina Rejas, Hans J. Schlitt, Matthias Hornung Tags: ORIGINAL RESEARCH Source Type: research